NKLR Terra Innovatum Global N.V. - Ordinary shares
$4.62
Price · Jul 2, 2026
Fundamentals as of Jul 1, 2026
52W Range
$4–$22
5% of range
Analyst Rating
BUY
11 analysts
Price Target
$17
+264% upside
P/E (TTM)
0.5
ROE
-1134.5%
Net Profit Margin
—
NKLR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.62
Market Cap
$509M
P/E (TTM)
0.5
EPS (TTM)
$9.74
Revenue (TTM)
—
Div Yield
—
ROE
-1134.5%
Debt/Equity
—
52W Range
$4 – $22
NKLR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$9.74
2025-12-31
→
2025-12-31
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NKLR
Peer Median
P/E (TTM)
0.5
8.0
P/B
-5.4
1.4
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NKLR
Peer Median
ROA
1015.4%
-43.2%
ROE
-1134.5%
-65.1%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NKLR
Peer Median
Current Ratio
33.6
1.8
Quick Ratio
32.6
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NKLR
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NKLR
Peer Median
NKLR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
11 analysts
- Strong Buy 2 18.2%
- Buy 8 72.7%
- Hold 1 9.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
5 analysts · 2026-07-05
Median
$19.00
Mean
$16.80
← Below all targets
$4.62
Low
$10.00
High
$25.00
Median target
$19.00
+311.3%
Mean target
$16.80
+263.6%
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $1M | $75.0K | |
| SG&A Expense | $32M | $78.0K | |
| Operating Expenses | $34M | $153.0K | |
| Operating Income | $-34M | $-153.0K | |
| Other Non-op | $573M | $129.0K | |
| Pretax Income | $540M | $-24.0K | |
| Income Tax | · | $10.0K | |
| Net Income | $540M | $-34.0K | |
| EPS (Basic) | $9.74 | · | |
| EPS (Diluted) | $9.74 | · | |
| Shares (Basic) | 55,407,007 | 47,500,000 | |
| Shares (Diluted) | 55,420,642 | 47,500,000 | |
| EBITDA | $-34M | · |
Balance Sheet 19
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $103M | $69.0K | |
| Receivables | $4.0K | · | |
| Prepaid Expense | $3M | $65.0K | |
| Current Assets | $106M | $134.0K | |
| PP&E (Net) | $102.0K | · | |
| PP&E (Gross) | $113.0K | · | |
| Accum. Depreciation | $11.0K | · | |
| Total Assets | $106M | $134.0K | |
| Accounts Payable | $1M | $32.0K | |
| Current Liabilities | $3M | $53.0K | |
| Other Non-current Liabilities | $8.0K | $6.0K | |
| Total Liabilities | $200M | $166.0K | |
| Common Stock | $1M | $551.0K | |
| Paid-in Capital | $519M | $-548.0K | |
| Retained Earnings | $-607M | $-37.0K | |
| AOCI | $-10M | $2.0K | |
| Stockholders' Equity | $-94M | $-32.0K | |
| Liabilities + Equity | $106M | $134.0K | |
| Shares Outstanding | 110,226,198 | 47,500,000 |
Cash Flow 4
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $20M | · | |
| Operating Cash Flow | $-10M | $-42.0K | |
| Investing Cash Flow | $-108.0K | · | |
| Financing Cash Flow | $112M | $112.0K |
Profitability 2
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | 1015.4% | · | |
| ROE | -1134.5% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 33.6 | · | |
| Quick Ratio | 32.6 | · |
Valuation (TTM) 6
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $540M | · | |
| Market Cap | $509M | · | |
| P/E | 0.5 | · | |
| P/B | -5.4 | · | |
| P / Cash Flow | -49.5 | · | |
| Earnings Yield | 210.8% | · |
Income Statement 12
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| R&D Expense | $1M | $1M | $155.0K | $22.0K | |
| SG&A Expense | $5M | $27M | $2M | $71.0K | |
| Operating Expenses | $7M | $28M | $2M | $93.0K | |
| Operating Income | $-7M | $-28M | $-2M | $-93.0K | |
| Other Non-op | $-472.0K | $573M | $-697.0K | $33.0K | |
| Pretax Income | $-7M | $545M | $-3M | $-60.0K | |
| Net Income | $-7M | $545M | $-3M | $-70.0K | |
| EPS (Basic) | $-0.06 | · | · | · | |
| EPS (Diluted) | $-0.06 | · | · | · | |
| Shares (Basic) | 110,226,198 | · | · | · | |
| Shares (Diluted) | 110,226,198 | · | · | · | |
| EBITDA | $-7M | · | $-2M | · |
Balance Sheet 19
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Cash & Equivalents | $97M | $103M | $2M | $69.0K | |
| Receivables | · | $4.0K | · | · | |
| Prepaid Expense | $5M | $3M | $385.0K | $65.0K | |
| Current Assets | $101M | $106M | $4M | $134.0K | |
| PP&E (Net) | $417.0K | $102.0K | $98.0K | · | |
| PP&E (Gross) | $434.0K | · | · | · | |
| Accum. Depreciation | $17.0K | · | · | · | |
| Total Assets | $102M | $106M | $4M | $134.0K | |
| Accounts Payable | $737.0K | $1M | $4M | $32.0K | |
| Current Liabilities | $5M | $3M | $7M | $53.0K | |
| Other Non-current Liabilities | $27.0K | $8.0K | $167.0K | $6.0K | |
| Total Liabilities | $201M | $200M | $8M | $166.0K | |
| Common Stock | $1M | $1M | · | $551.0K | |
| Paid-in Capital | $519M | $519M | $1M | $-548.0K | |
| Retained Earnings | $-614M | $-607M | $-6M | $-37.0K | |
| AOCI | $-8M | $-10M | $-30.0K | $2.0K | |
| Stockholders' Equity | $-99M | $-94M | $-4M | $-32.0K | |
| Liabilities + Equity | $102M | $106M | $4M | $134.0K | |
| Shares Outstanding | 110,226,198 | 110,226,198 | · | 47,500,000 |
Cash Flow 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-4M | $-7M | · | $-54.0K | |
| Investing Cash Flow | $-328.0K | $-14.0K | · | · | |
| Financing Cash Flow | · | $107M | · | · |
Profitability 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| ROA | -14.0% | · | -159.4% | · | |
| ROE | 14.4% | · | 141.2% | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Current Ratio | 21.3 | · | 0.5 | · | |
| Quick Ratio | 20.3 | · | 0.3 | · |
Valuation (TTM) 4
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Net Income TTM | $-13M | · | $-6M | · | |
| Market Cap | $511M | · | · | · | |
| P/B | -5.2 | · | · | · | |
| P / Cash Flow | -132.6 | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Net Income | $540M | $-34.0K |
| Diluted EPS | $9.74 | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Current Ratio | 33.6 | — |
| Quick Ratio | 32.6 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.